West Pharmaceutical Services SG&A Expenses 2010-2025 | WST

West Pharmaceutical Services annual/quarterly sg&a expenses history and growth rate from 2010 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • West Pharmaceutical Services sg&a expenses for the quarter ending March 31, 2025 were $88M, a 1.5% increase year-over-year.
  • West Pharmaceutical Services sg&a expenses for the twelve months ending March 31, 2025 were $0.340B, a 4.04% decline year-over-year.
  • West Pharmaceutical Services annual sg&a expenses for 2024 were $0.339B, a 4.22% decline from 2023.
  • West Pharmaceutical Services annual sg&a expenses for 2023 were $0.353B, a 11.52% increase from 2022.
  • West Pharmaceutical Services annual sg&a expenses for 2022 were $0.317B, a 12.65% decline from 2021.
West Pharmaceutical Services Annual SG&A Expenses
(Millions of US $)
2024 $339
2023 $353
2022 $317
2021 $363
2020 $302
2019 $273
2018 $263
2017 $246
2016 $240
2015 $233
2014 $229
2013 $235
2012 $218
2011 $191
2010 $188
2009 $178
West Pharmaceutical Services Quarterly SG&A Expenses
(Millions of US $)
2025-03-31 $88
2024-12-31 $85
2024-09-30 $84
2024-06-30 $83
2024-03-31 $87
2023-12-31 $90
2023-09-30 $89
2023-06-30 $88
2023-03-31 $86
2022-12-31 $86
2022-09-30 $66
2022-06-30 $82
2022-03-31 $83
2021-12-31 $98
2021-09-30 $92
2021-06-30 $93
2021-03-31 $80
2020-12-31 $76
2020-09-30 $76
2020-06-30 $78
2020-03-31 $72
2019-12-31 $69
2019-09-30 $65
2019-06-30 $70
2019-03-31 $69
2018-12-31 $60
2018-09-30 $65
2018-06-30 $70
2018-03-31 $68
2017-12-31 $60
2017-09-30 $63
2017-06-30 $61
2017-03-31 $63
2016-12-31 $61
2016-09-30 $58
2016-06-30 $63
2016-03-31 $58
2015-12-31 $62
2015-09-30 $55
2015-06-30 $61
2015-03-31 $55
2014-12-31 $59
2014-09-30 $56
2014-06-30 $58
2014-03-31 $56
2013-12-31 $60
2013-09-30 $56
2013-06-30 $60
2013-03-31 $59
2012-12-31 $59
2012-09-30 $54
2012-06-30 $54
2012-03-31 $51
2011-12-31 $48
2011-09-30 $46
2011-06-30 $46
2011-03-31 $51
2010-12-31 $50
2010-09-30 $45
2010-06-30 $46
2010-03-31 $47
2009-12-31 $45
2009-09-30 $44
2009-06-30 $45
2009-03-31 $43
Sector Industry Market Cap Revenue
Medical MED/DENTAL-SUPP $15.106B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) US $88.577B 24.24
Becton Dickinson (BDX) US $48.681B 12.03
Cardinal Health (CAH) US $35.155B 18.19
Labcorp (LH) US $20.195B 16.38
Straumann Holding AG (SAUHY) CH $19.454B 0.00
Cooper (COO) US $16.226B 21.52
Align Technology (ALGN) US $12.939B 25.43
Henry Schein (HSIC) US $7.897B 13.60
Merit Medical Systems (MMSI) US $5.508B 26.63
DENTSPLY SIRONA (XRAY) US $2.776B 8.34
CONMED (CNMD) US $1.769B 13.24
STAAR Surgical (STAA) US $0.908B 0.00
Pro-Dex (PDEX) US $0.219B 24.04
Lifevantage (LFVN) US $0.147B 16.26